LOC105375361: A novel protein with potential as a drug target and biomarker
LOC105375361: A novel protein with potential as a drug target and biomarker
LOC105375361 is a novel protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an intriguing target for researchers to study, and its potential as a drug may have significant implications for the treatment of these diseases.
LOC105375361 is a member of the T-cell receptor (TCR) family, which is a critical signaling pathway in the immune system. TCRs are responsible for recognizing and responding to foreign substances in the body, such as viruses and bacteria. LOC105375361 is a cytoplasmic protein that is expressed in most tissues of the body, including the brain, spleen, and pancreas.
Its unique structure is what makes LOC105375361 an attractive drug target. The protein has four structural domains: a N-terminus that contains a leucine-rich repeat, a middle domain that contains a single alpha-helix, and two C-terminus domains that contain a tyrosine-rich repeat and a benzimidazole-containing domain. The C-terminus domains are responsible for the protein's stability and interactions with other proteins, and the tyrosine-rich repeat is known to play a role in the regulation of protein function.
Research has shown that LOC105375361 is involved in various immune and non-immune processes in the body. For example, it has been shown to be involved in the regulation of T-cell proliferation and differentiation, as well as the production of antibodies by B cells . Additionally, LOC105375361 has been shown to play a role in the regulation of inflammation and immune cell function.
As a potential drug target, LOC105375361 has the potential to intervene in a variety of diseases. For example, LOC105375361 has been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, the protein has has been shown to be involved in the regulation of cancer cell growth and survival, which may make it an attractive target for cancer therapies.
In addition to its potential as a drug target, LOC105375361 has also been identified as a potential biomarker for several diseases. For example, the protein has been shown to be involved in the regulation of inflammation and immune cell function, which may make it an attractive target for therapies aimed at reducing inflammation and improving immune function. Additionally, the protein's unique structure and function may make it an attractive target for diagnostic tools, as its expression and function may be affected by various diseases.
In conclusion, LOC105375361 is a novel and intriguing protein that has the potential to be a drug target and biomarker for a variety of diseases. Its unique structure and function make it an attractive target for research into the regulation of immune and non-immune processes in the body, as well as its potential as a drug or diagnostic tool. Further research is needed to fully understand the protein's role in these processes and its potential as a drug.
Protein Name: Uncharacterized LOC105375361
The "LOC105375361 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105375361 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105375379 | LOC105375381 | LOC105375404 | LOC105375410 | LOC105375423 | LOC105375428 | LOC105375429 | LOC105375434 | LOC105375440 | LOC105375443 | LOC105375448 | LOC105375451 | LOC105375452 | LOC105375490 | LOC105375492 | LOC105375494 | LOC105375508 | LOC105375523 | LOC105375536 | LOC105375541 | LOC105375543 | LOC105375552 | LOC105375556 | LOC105375567 | LOC105375574 | LOC105375597 | LOC105375600 | LOC105375610 | LOC105375623 | LOC105375629 | LOC105375631 | LOC105375639 | LOC105375655 | LOC105375670 | LOC105375672 | LOC105375683 | LOC105375690 | LOC105375704 | LOC105375712 | LOC105375716 | LOC105375721 | LOC105375725 | LOC105375730 | LOC105375733 | LOC105375739 | LOC105375741 | LOC105375743 | LOC105375745 | LOC105375751 | LOC105375753 | LOC105375755 | LOC105375779 | LOC105375785 | LOC105375787 | LOC105375805 | LOC105375825 | LOC105375836 | LOC105375855 | LOC105375856 | LOC105375861 | LOC105375875 | LOC105375896 | LOC105375903 | LOC105375911 | LOC105375914 | LOC105375920 | LOC105375922 | LOC105375925 | LOC105375928 | LOC105375931 | LOC105375938 | LOC105375943 | LOC105375951 | LOC105375962 | LOC105375974 | LOC105375976 | LOC105375977 | LOC105375983 | LOC105375984 | LOC105375990 | LOC105375999 | LOC105376001 | LOC105376014 | LOC105376017 | LOC105376035 | LOC105376081 | LOC105376107 | LOC105376110 | LOC105376136 | LOC105376139 | LOC105376156 | LOC105376157 | LOC105376158 | LOC105376161 | LOC105376169 | LOC105376171 | LOC105376177 | LOC105376187 | LOC105376193 | LOC105376196
